Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Hackman Jeffrey S. received 1,159 Fennec Pharmaceuticals Inc. shares as an award (Form 4)

Traded Jun 30, 2026 · Filed Jul 1, 2026

On Jun 30, 2026, Hackman Jeffrey S. (Director, Chief Executive Officer) received 1,159 Fennec Pharmaceuticals Inc. shares as an award, leaving 63,984 shares. Filed Jul 1, 2026 (Form 4).

Awarded
1,159 shares
Holding after
63,984 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 30, 2026Common SharesAward1,15963,984Direct

Source

View original at SEC

Related